75,000 Shares in Kestra Medical Technologies, Ltd. $KMTS Bought by Ghisallo Capital Management LLC

Key Points

• Ghisallo Capital Management LLC has acquired a new position in Kestra Medical Technologies, Ltd. worth approximately $1.87 million during the first quarter, consisting of 75,000 shares.
• Several hedge funds, including Omega Fund Management and T. Rowe Price Investment Management, have also established new stakes in Kestra Medical Technologies, indicating growing institutional interest in the company.
• Wells Fargo & Company has reduced its target price for Kestra Medical Technologies from $28.00 to $27.00, while the stock currently holds a consensus rating of "Moderate Buy" with a target price of $27.33.

Ghisallo Capital Management LLC purchased a new position in shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 75,000 shares of the company's stock, valued at approximately $1,869,000. Ghisallo Capital Management LLC owned about 0.15% of Kestra Medical Technologies at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of KMTS. Quarry LP purchased a new stake in Kestra Medical Technologies in the 1st quarter worth approximately $33,000. Virtu Financial LLC purchased a new stake in Kestra Medical Technologies in the 1st quarter worth approximately $210,000. Armistice Capital LLC purchased a new stake in Kestra Medical Technologies in the 1st quarter worth approximately $312,000. Russell Investments Group Ltd. purchased a new position in shares of Kestra Medical Technologies in the 1st quarter valued at approximately $457,000. Finally, Caas Capital Management LP purchased a new position in shares of Kestra Medical Technologies in the 1st quarter valued at approximately $1,470,000.

Kestra Medical Technologies Stock Down 2.7%

Shares of Kestra Medical Technologies stock traded down $0.45 on Thursday, reaching $16.51. The company's stock had a trading volume of 232,171 shares, compared to its average volume of 270,871. The company's fifty day moving average price is $16.19. Kestra Medical Technologies, Ltd. has a 52 week low of $13.25 and a 52 week high of $26.15. The company has a current ratio of 6.72, a quick ratio of 6.72 and a debt-to-equity ratio of 0.20.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company lowered their target price on Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a research note on Thursday, July 17th. Five investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, Kestra Medical Technologies currently has a consensus rating of "Moderate Buy" and an average target price of $27.33.

Kestra Medical Technologies Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.